An

endothelin receptor antagonist

(ERA) is a drug that blocks endothelin receptors. Three main kinds of ERAs exist: selective ETA receptor antagonists (sitaxentan, ambrisentan, atrasentan, BQ-123, zibotentan), which affect endothelin A receptors.